IBRX
ImmunityBio (IBRX) Earnings
Review ImmunityBio (IBRX) earnings with server-rendered company data, supporting context and links to related investor research.
- Annual EPS
- -0.38
- Trailing EPS
- -0.97
- Annual revenue
- $113.29M
- Trailing revenue
- $165.80M
- Next earnings date
- 2026-08-07
- Earnings data source
- MarketBeat historical revenue consensus + S&P Global consensus via StockAnalysis + Finnhub earnings
ImmunityBio (IBRX) Earnings research
The IBRX earnings page organizes the available earnings-per-share and revenue context for ImmunityBio. Earnings trends are more informative when actual results are compared with prior periods, market expectations and management guidance.
Quarterly surprises can move a share price, but their long-term importance depends on margins, cash flow and the durability of demand. Continue to the financials and valuation pages for a broader view.